Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-13-012893
Filing Date
2013-04-02
Accepted
2013-04-02 16:08:20
Documents
2
Period of Report
2013-03-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3574
2 POWER OF ATTORNEY doc1.htm EX-24 4807
  Complete submission text file 0001127602-13-012893.txt   9681
Mailing Address 65 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE LEXINGTON MA 02421 781-860-8660
CUBIST PHARMACEUTICALS INC (Issuer) CIK: 0000912183 (see all company filings)

EIN.: 223192085 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
GILMAN STEVEN C (Reporting) CIK: 0001379970 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21379 | Film No.: 13735397